Form 4: Tectonic Therapeutic CFO Acquires 118,000 Stock Options
SEC Form 4 Filing
Daniel Lochner, CFO of Tectonic Therapeutic, Inc., reports the acquisition of 118,000 employee stock options.
Summary
- Daniel Lochner, the Chief Financial Officer of Tectonic Therapeutic, Inc., acquired 118,000 employee stock options on June 20, 2024.
- The options have an exercise price of $16.80.
- 25% of the shares vest on June 20, 2025, with the remaining shares vesting in 36 equal monthly installments, contingent upon continued service and potential change of control acceleration.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it simply reports a transaction by a company officer. It doesn't inherently indicate positive or negative performance.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track management's alignment with shareholder interests.
Stakeholder Impact
- The acquisition of stock options by the CFO aligns his interests with those of the shareholders, potentially incentivizing him to improve company performance.
Key Dates
| Date | Description |
|---|---|
| 06/20/2024 | Date of earliest transaction: CFO acquired 118,000 employee stock options. |
| 06/20/2025 | 25% of the acquired stock options vest. |
| 06/19/2034 | Expiration date of the employee stock options. |
| 06/24/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.